Related Experiment Video
Updated: Jul 20, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
Irfan A Dhalla1, Muhammad M Mamdani, Andrew E Simor
1Department of Medicine, Unversity of Toronto, Ontario M4E 3E9, Canada. irfan.dhalla@utoronto.ca
Abstract:
Limited evidence suggests that broad-spectrum fluoroquinolones such as gatifloxacin and moxifloxacin are more likely to cause Clostridium difficile-associated disease than levofloxacin. In a population-based case-control study of outpatients prescribed fluoroquinolones, we found no increased risk of C. difficile-associated disease requiring hospitalization among patients prescribed gatifloxacin or moxifloxacin compared to levofloxacin.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Gene Regulation in Microbial Communities: Quorum Sensing
Dysbiosis of the Gut Microbiota
Clinical Significance of Antibiotic Resistance
